The Baltics Today

Latvian Olainfarm posts EUR 66.9 mln in sales in 2013

Consolidated profit and loss account of the Latvian joint-stock pharmaceutical company Olainfarm for 2013 shows that the company achieved EUR 77.9 million in sales last year, an increase of 4% compared to 2012, according to the company's statement submitted to the "NASDAQ OMX Riga" stock exchange, reports LETA/Nozare.lv.... Read more...

Comments are closed.